Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: Results from the INFUSE-AMI study

Catheterization and Cardiovascular Interventions

Volumn 83, Issue 5, 2014, Pages 704-710

  Sanidas, Elias A ^a   Brener, Sorin J ^a,b   Maehara, Akiko ^a,c   Généreux, Philippe ^a,d   Witzenbichler, Bernhard ^e   El Omar, Magdi ^f   Fahy, Martin ^a   Mehran, Roxana ^a,g   Gibson, C Michael ^h   Stone, Gregg W ^a,c  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b NEW YORK METHODIST HOSPITAL   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f Manchester Heart Center   (United Kingdom)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

diabetes mellitus; infarct size; myocardial infarction; primary PCI

Indexed keywords

ABCIXIMAB; HIRULOG; INSULIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OCCLUSION; CORONARY STENT; DIABETES MELLITUS; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THERAPY EFFECT; THROMBUS ASPIRATION; TREATMENT OUTCOME;

DIABETES MELLITUS; INFARCT SIZE; MYOCARDIAL INFARCTION; PRIMARY PCI;

AGED; ANTERIOR WALL MYOCARDIAL INFARCTION; ANTIBODIES, MONOCLONAL; ANTITHROMBINS; CEREBROVASCULAR DISORDERS; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DIABETES COMPLICATIONS; FEMALE; HIRUDINS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899464973     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25203     Document Type: Article

References (29)

1. American College of Emergency P, Society for Cardiovascular A, Interventions, O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW,. 2013 accf/aha guideline for the management of ST-elevation myocardial infarction: Executive summary: A report of the american college of cardiology foundation/american heart association task force on practice guidelines. J Am Coll Cardiol 2013; 61: 485-510.
2. Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, Califf RM, Topol EJ,. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. Gusto-i investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. J Am Coll Cardiol 1997; 30: 171-179.
3. Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, Antman EM,. Diabetes and mortality following acute coronary syndromes. JAMA 2007; 298: 765-775.
4. van der Schaaf RJ, Henriques JP, Wiersma JJ, Koch KT, Baan J Jr, Mulder KJ, Durrer JD, Tijssen JG, Piek JJ, de Winter RJ,. Primary percutaneous coronary intervention for patients with acute ST elevation myocardial infarction with and without diabetes mellitus. Heart 2006; 92: 117-118.
5. Stone GW, Maehara A, Witzenbichler B, Godlewski J, Parise H, Dambrink JH, Ochala A, Carlton TW, Cristea E, Wolff SD, Brener SJ, Chowdhary S, El-Omar M, Neunteufl T, Metzger DC, Karwoski T, Dizon JM, Mehran R, Gibson CM, Investigators I-A,. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: The infuse-ami randomized trial. JAMA 2012; 307: 1817-1826.
6. Gibson CM, Maehara A, Lansky AJ, Wohrle J, Stuckey T, Dave R, Cox D, Grines C, Dudek D, Steg G, Parise H, Wolff SD, Cristea E, Stone GW,. Rationale and design of the infuse-ami study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. Am Heart J 2011; 161: 478-486.e7.
7. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW, the syntax score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-227.
8. Califf RM, Phillips HR, III, Hindman, MC, Mark, DB, Lee, KL, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 1985; 5: 1055-1063.
9. Lindvall B, Brorsson B, Herlitz J, Albertsson P, Werko L,. Comparison of diabetic and non-diabetic patients referred for coronary angiography. Int J Cardiol 1999; 70: 33-42.
10. Harjai KJ, Grines C, Stone GW, Boura J, Turco M, Brodie B, Sadeghi HM, Cox D, Grines L, O' Neill WW,. Frequency, determinants, and clinical implications of residual intracoronary thrombus following primary angioplasty for acute myocardial infarction. Am J Cardiol 2003; 92: 377-382.
11. Bypass Angioplasty Revascularization Investigation 2 Diabetes Study G. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the bypass angioplasty revascularization investigation 2 diabetes (bari 2d) trial. Am Heart J 2008; 156: 528-536, 536.e1-e5.
12. Flaherty JD, Davidson CJ,. Diabetes and coronary revascularization. JAMA 2005; 293: 1501-1508.
13. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ, American Heart A, American Diabetes A. Primary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the american heart association and the american diabetes association. Circulation 2007; 115: 114-126.
14. Marso SP, Miller T, Rutherford BD, Gibbons RJ, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Mehran R, Krucoff MW, Lansky AJ, Stone GW,. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the emerald trial). Am J Cardiol 2007; 100: 206-210.
15. Prasad A, Stone GW, Stuckey TD, Costantini CO, Zimetbaum PJ, McLaughlin M, Mehran R, Garcia E, Tcheng JE, Cox DA, Grines CL, Lansky AJ, Gersh BJ,. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 2005; 45: 508-514.
16. Timmer JR, van der Horst IC, de Luca G, Ottervanger JP, Hoorntje JC, de Boer MJ, Suryapranata H, Dambrink JH, Gosselink M, Zijlstra F, van 't Hof AW, Zwolle Myocardial Infarction Study G. Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus. Am J Cardiol 2005; 95: 1375-1377.
17. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD,. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995; 91: 635-640.
18. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A,. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999; 99: 2239-2242.
19. Brener SJ, Mehran R, Dressler O, Cristea E, Stone GW,. Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI). Am J Cardiol 2012; 109: 1111-1116.
20. Minha S, Bental T, Assali A, Vaknin-Assa H, Lev EI, Rechavia E, Battler A, Kornowski R,. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients. Catheter Cardiovasc Interv 2011; 78: 710-717.
21. De Luca G, Suryapranata H, Timmer J, Ottervanger JP, van 't Hof AW, Hoorntje JC, Dambrink JH, Gosselink AT, de Boer MJ,. Impact of routine stenting on clinical outcome in diabetic patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Diabetes Care 2006; 29: 920-923.
22. Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, Shiode N, Namura M, Sone T, Oshima S, Nishikawa H, Hiasa Y, Hayashi Y, Nobuyoshi M, Mitudo K, j-Cypher Registry I,. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: Five-year outcome of the j-cypher registry. Circulation 2012; 125: 584-591.
23. Armstrong EJ, Feldman DN, Wang TY, Kaltenbach LA, Yeo KK, Wong SC, Spertus J, Shaw RE, Minutello RM, Moussa I, Ho KK, Rogers JH, Shunk KA,. Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. JACC Cardiovasc Interv 2012; 5: 131-140.
24. De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz, de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW, cooperation D,. Impact of diabetes on long-term outcome after primary angioplasty: Insights from the desert cooperation. Diabetes Care 2013; 36: 1020-1025.
25. De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz, de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW, DESERT Cooperation. Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention. Am J Cardiol 2013; 111: 1295-1304.
26. Thiele H, Schindler K, Friedenberger J, Eitel I, Furnau G, Grebe E, Erbs S, Linke A, Mobius-Winkler S, Kivelitz D, Schuler G,. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: The randomized leipzig immediate percutaneous coronary intervention abciximab iv versus ic in ST-elevation myocardial infarction trial. Circulation 2008; 118: 49-57.
27. Gu YL, Kampinga MA, Wieringa WG, Fokkema ML, Nijsten MW, Hillege HL, van den Heuvel AF, Tan ES, Pundziute G, van der Werf R, Hoseyni Guyomi S, van der Horst IC, Zijlstra F, de Smet BJ,. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: The comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (cicero) trial. Circulation 2010; 122: 2709-2717.
28. Svilaas T, Vlaar PJ, van der Horst IC, Diercks GF, de Smet BJ, van den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, Zijlstra F,. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008; 358: 557-567.
29. Kaltoft A, Bottcher M, Nielsen SS, Hansen HH, Terkelsen C, Maeng M, Kristensen J, Thuesen L, Krusell LR, Kristensen SD, Andersen HR, Lassen JF, Rasmussen K, Rehling M, Nielsen TT, Botker HE,. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: A randomized, controlled trial. Circulation 2006; 114: 40-47.